Panosome

Heidelberg, Germany

Panosome is a biotech startup with a novel, proprietary platform to generate antibodies to small molecules, peptides, and proteins.

$3.4M raised

Jun 2024

Seed

Top Investors

German Federal Ministry of Education and ResearchBusiness Angelsencourageventures

19,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has Panosome raised?

Panosome has raised $3.4M in total funding. The most recent round was Seed. The last funding was announced in June 2024.

Who are Panosome's investors?

Panosome's investors include German Federal Ministry of Education and Research, Business Angels, encourageventures.

Where is Panosome headquartered?

Panosome is headquartered in Heidelberg, Germany.

What does Panosome do?

Panosome is a biotech startup with a novel, proprietary platform to generate antibodies to small molecules, peptides, and proteins.

What stage is Panosome at?

Panosome is at the Seed stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated June 29, 2024.

MLA

"Panosome — Funding & Investors." VCBacked, June 29, 2024, https://www.vcbacked.co/company/panosome. Accessed June 17, 2026.

APA

VCBacked. (2024). Panosome — Funding & Investors. Retrieved June 17, 2026, from https://www.vcbacked.co/company/panosome

Wikipedia (cite web)

{{cite web |title=Panosome — Funding & Investors |url=https://www.vcbacked.co/company/panosome |website=VCBacked |access-date=June 17, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated June 29, 2024.